Effects of Liver Fibrosis on Islet Function in Patients with Chronic Hepatitis B Complicated with Impaired Fasting Glucose

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2023 Nov 29

PMID 38021063

Authors

Yan Lu

Wei Gou

Hai Feng Zhang

Yi Ying Li

Affiliations

Soon will be listed here.

Abstract

Background: Patients with chronic hepatitis B (CHB) and cirrhosis often have impaired fasting glucose (IFG). This study sought to investigate the impact of liver fibrosis on islet function in individuals diagnosed with CHB and IFG.

Material And Methods: Patients with chronic hepatitis B (CHB) and impaired fasting glucose (IFG) were selected for this study. They were divided into low-risk (L-R), intermediate-risk (M-R), and high-risk (H-R) liver fibrosis groups based on the FIB-4 score. The study compared islet function among different risk groups of liver fibrosis and analyze the correlation between liver fibrosis and islet function. Additionally, the patients were divided into a diabetes mellitus (DM) group and a non-DM (NDM) group based on the development of DM. The cumulative risk of progression to DM in patients with L-R, M-R, and H-R liver fibrosis was analyzed using the Kaplan-Meier method. Hazard ratios (HRs) and confidence intervals (CIs) were calculated for DM development through Cox regression analysis.

Results: In this study of 228 individuals, higher FIB-4 scores were observed in the DM group compared to the NDM group. Patients with H-R liver fibrosis displayed lower islet function and had a significantly higher risk of developing DM. The FIB-4 score and fasting plasma glucose (FPG) were identified as independent risk factors for DM progression in CHB patients with IFG.

Conclusion: Among patients with CHB and IFG, the severity of liver fibrosis is associated with islet function, and the FIB-4 score is a significant risk factor for DM development.

References

Blanco J, Herrero J, Quiroga J, Sangro B, Pardo F, A Cienfuegos J . Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl. 2001; 7(3):226-33. DOI: 10.1053/jlts.2001.22183. View

Grancini V, Trombetta M, Lunati M, Zimbalatti D, Boselli M, Gatti S . Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease. J Hepatol. 2015; 63(6):1484-90. DOI: 10.1016/j.jhep.2015.08.011. View

Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H . Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020; 369:m997. PMC: 7186854. DOI: 10.1136/bmj.m997. View

Kuroda T, Hirooka M, Koizumi M, Ochi H, Hisano Y, Bando K . Pancreatic congestion in liver cirrhosis correlates with impaired insulin secretion. J Gastroenterol. 2014; 50(6):683-93. DOI: 10.1007/s00535-014-1001-8. View

Merli M, Leonetti F, Riggio O, Valeriano V, Ribaudo M, Strati F . Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology. 1999; 30(3):649-54. DOI: 10.1002/hep.510300306. View

Perseghin G, Mazzaferro V, Sereni L, Regalia E, Benedini S, Bazzigaluppi E . Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology. 2000; 31(3):694-703. DOI: 10.1002/hep.510310320. View

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2017; 41(Suppl 1):S13-S27. DOI: 10.2337/dc18-S002. View

Lin C, Adhikary P, Cheng K . Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv Drug Deliv Rev. 2021; 174:127-139. PMC: 8217274. DOI: 10.1016/j.addr.2021.04.008. View

Kisseleva T, Brenner D . Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2020; 18(3):151-166. DOI: 10.1038/s41575-020-00372-7. View

10.

Iversen J, Vilstrup H, Tygstrup N . Kinetics of glucose metabolism in relation to insulin concentrations in patients with alcoholic cirrhosis and in healthy persons. Gastroenterology. 1984; 87(5):1138-43. View

11.

Grancini V, Trombetta M, Lunati M, Boselli M, Gatti S, Donato M . Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients. J Hepatol. 2019; 70(5):954-962. DOI: 10.1016/j.jhep.2019.01.015. View

12.

Orsi E, Grancini V, Menini S, Aghemo A, Pugliese G . Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?. Liver Int. 2016; 37(7):950-962. DOI: 10.1111/liv.13337. View

13.

Kim B, Kim D, Park J, Ahn S, Chon C, Kim J . Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int. 2010; 30(4):546-53. DOI: 10.1111/j.1478-3231.2009.02192.x. View

14.

Lomonaco R, Godinez Leiva E, Bril F, Shrestha S, Mansour L, Budd J . Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening. Diabetes Care. 2020; 44(2):399-406. PMC: 7818321. DOI: 10.2337/dc20-1997. View

15.

Sakata M, Kawahara A, Kawaguchi T, Akiba J, Taira T, Taniguchi E . Decreased expression of insulin and increased expression of pancreatic transcription factor PDX-1 in islets in patients with liver cirrhosis: a comparative investigation using human autopsy specimens. J Gastroenterol. 2012; 48(2):277-85. DOI: 10.1007/s00535-012-0633-9. View

16.

Garcia-Compean D, Jaquez-Quintana J, Lavalle-Gonzalez F, Reyes-Cabello E, Gonzalez-Gonzalez J, Munoz-Espinosa L . The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study. Ann Hepatol. 2012; 11(2):240-8. View

17.

Ishikawa T, Shiratsuki S, Matsuda T, Iwamoto T, Takami T, Uchida K . Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension. J Gastroenterol. 2013; 49(9):1333-41. DOI: 10.1007/s00535-013-0893-z. View

18.

PETRIDES A, Vogt C, Matthews D, Strohmeyer G . Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology. 1993; 18(2):284-91. View

19.

Ciardullo S, Monti T, Perseghin G . High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes. Diabetes Care. 2020; 44(2):519-525. DOI: 10.2337/dc20-1778. View

20.

Gines P, Krag A, Abraldes J, Sola E, Fabrellas N, Kamath P . Liver cirrhosis. Lancet. 2021; 398(10308):1359-1376. DOI: 10.1016/S0140-6736(21)01374-X. View